Cogent Biosciences, Inc. - Common Stock (NQ:COGT)

37.87 -0.48 (-1.25%)

Streaming Delayed Price Updated: 10:20 AM EST, Feb 19, 2026 Add to My Watchlist

Price and Volume

Volume	193,266
Open	37.88
Bid (Size)	37.71 (200)
Ask (Size)	38.01 (100)
Prev. Close	38.35
Today's Range	37.03 - 38.16
52wk Range	3.720 - 43.73
Shares Outstanding	85,465,249
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗

February 17, 2026

This biotech firm develops precision therapies targeting rare genetic diseases, with a lead candidate focused on oncology indications.

Via The Motley Fool

Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗

February 17, 2026

Cogent Biosciences develops precision therapies for genetically defined diseases, with a pipeline targeting rare oncological conditions.

Via The Motley Fool

Performance

YTD	+9.0%	+9.0%
1 Month	-5.1%	-5.1%
3 Month	+8.4%	+8.4%
6 Month	+219.2%	+219.2%
1 Year	+367.5%	+367.5%

More News

Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M ↗

February 01, 2026

Via The Motley Fool

Cogent Insider Sells $2.5 Million in Stock Amid Staggering 300% Price Surge ↗

January 11, 2026

Via The Motley Fool

What's going on in today's after hours session ↗

December 30, 2025

Via Chartmill

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗

December 09, 2025

Via The Motley Fool

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗

December 09, 2025

Via The Motley Fool

Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets ↗

December 09, 2025

Via The Motley Fool

With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? ↗

December 03, 2025

Via The Motley Fool

Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away ↗

December 03, 2025

Via The Motley Fool

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗

December 03, 2025

Via The Motley Fool

Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares ↗

December 03, 2025

Via The Motley Fool

This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗

November 17, 2025

Via The Motley Fool

This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗

November 17, 2025

Via The Motley Fool

Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗

November 17, 2025

Via The Motley Fool

This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗

November 17, 2025

Via The Motley Fool

Top movers analysis one hour before the close of the markets on 2025-11-10: top gainers and losers in today's session. ↗

November 10, 2025

Via Chartmill

Top movers in Monday's session ↗

November 10, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 10, 2025

Via Benzinga

Gold Jumps Over 2%; Dole Shares Gain After Q3 Results ↗

November 10, 2025

Via Benzinga

Cogent Biosciences Hits 7-Year High, Up 120% On Its New Stomach Cancer Promise ↗

November 10, 2025

Via Investor's Business Daily

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 10, 2025

Via Chartmill

Cogent Biosciences' Lead Cancer Drug Cuts Disease Progression Or Death Risk By 50% In Stomach Cancer Trial ↗

November 10, 2025

Via Benzinga

Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday ↗

November 10, 2025

Via Benzinga

S&P 500 Surges 1%; Tyson Foods Posts Upbeat Earnings ↗

November 10, 2025

Via Benzinga

Frequently Asked Questions

Is Cogent Biosciences, Inc. - Common Stock publicly traded?

Yes, Cogent Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Cogent Biosciences, Inc. - Common Stock trade on?

Cogent Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Cogent Biosciences, Inc. - Common Stock?

The ticker symbol for Cogent Biosciences, Inc. - Common Stock is COGT on the Nasdaq Stock Market

What is the current price of Cogent Biosciences, Inc. - Common Stock?

The current price of Cogent Biosciences, Inc. - Common Stock is 37.87

When was Cogent Biosciences, Inc. - Common Stock last traded?

The last trade of Cogent Biosciences, Inc. - Common Stock was at 02/19/26 10:20 AM ET

What is the market capitalization of Cogent Biosciences, Inc. - Common Stock?

The market capitalization of Cogent Biosciences, Inc. - Common Stock is 3.24B

How many shares of Cogent Biosciences, Inc. - Common Stock are outstanding?

Cogent Biosciences, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.